{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:05:52Z","timestamp":1782547552588,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,2,12]],"date-time":"2005-02-12T00:00:00Z","timestamp":1108166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s00228-004-0876-3","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T10:48:57Z","timestamp":1108118937000},"page":"127-133","source":"Crossref","is-referenced-by-count":14,"title":["The application of prescribing indicators to a primary care prescription database in Ireland"],"prefix":"10.1007","volume":"61","author":[{"given":"D.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Feely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,2,12]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/13814789709160336","volume":"3","author":"M Lawrence","year":"1997","unstructured":"Lawrence M, Olesen F (1997) Indicators of quality in health care. Eur J Gen Pract 3:103","journal-title":"Eur J Gen Pract"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/qshc.7.3.130","volume":"7","author":"J Cantrill","year":"1998","unstructured":"Cantrill J, Sibbald B, Buetow S (1998) Indicators of the appropriateness of long term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability. Qual Health Care 7:130","journal-title":"Qual Health Care"},{"key":"CR3","unstructured":"Audit Commission (1994) A prescription for improvement; towards more rational prescribing in general practice. HMSO"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00019053-199202020-00003","volume":"2","author":"J Feely","year":"1992","unstructured":"Feely J (1992) The influence of pharmacoeconomic factors on prescribing patterns in Ireland. Pharmacoeconomics 2:99","journal-title":"Pharmacoeconomics"},{"key":"CR5","unstructured":"General Medical Services (Payments) Board (2000) Report for the year ended 31st December"},{"key":"CR6","first-page":"20","volume":"46","author":"DN Bateman","year":"1996","unstructured":"Bateman DN, Eccles M, Campbell M, Soutter J, Roberts SJ, Smith J (1996) Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. Br J Gen Pract 46:20","journal-title":"Br J Gen Pract"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1099-1557(199607)5:4<237::AID-PDS218>3.0.CO;2-X","volume":"5","author":"S Thomas","year":"1996","unstructured":"Thomas S, Campbell M (1996) Utilisation of appetite suppressants in England: a putative indicator of poor prescribing practice. Pharmacoepidemiol Drug Saf 5:237","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/oxfordjournals.pubmed.a024796","volume":"20","author":"SM Campbell","year":"1998","unstructured":"Campbell SM, Roland MO, Qualye JA, Shekelle PG, Buetow S (1998) Quality indicators for General Practice; Which ones can general practitioners and health authority managers agree are important and how useful are they? J Public Health Med 20:414","journal-title":"J Public Health Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2836(02)00592-2","volume":"321","author":"S Campbell","year":"2002","unstructured":"Campbell S, Cantrill J, Roberts D (2002) Prescribing indicators for UK general practice: Delphi consultation study, BMJ 21:1","journal-title":"BMJ"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2125.1997.tb00038.x","volume":"43","author":"A Oborne","year":"1997","unstructured":"Oborne A, Batty G, Maskrey V, Swift C, Jackson S (1997) Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 43:91","journal-title":"Br J Clin Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/bmj.327.7419.845","volume":"327","author":"B Lawton","year":"2003","unstructured":"Lawton B, Rose S, McLeod D, Dowell A (2003) Changes in use of hormone replacement therapy after the report from the Women\u2019s Health Initiative: cross sectional survey of users. BMJ 327:845","journal-title":"BMJ"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","volume":"337","author":"HM Connolly","year":"1997","unstructured":"Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV (1997) Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337:581","journal-title":"N Engl J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1099-1557(199709\/10)6:5<337::AID-PDS298>3.0.CO;2-P","volume":"6","author":"Z Johnson","year":"1997","unstructured":"Johnson Z, Hayes C, Dack P (1997) The standardised prescribing ratio\u2014a new method for comparing prescribing between GPs, controlling for patient age and sex. Pharmacoepidemiol Drug Saf 6:337","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"CR14","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (1996) Guidelines For DDD. Oslo"},{"key":"CR15","unstructured":"Roland M, Holden J, Campbell S (1999) Quality Assessment for General Practice. National Primary Care Research and Development Centre"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2710.1998.00187.x","volume":"23","author":"AJ Avery","year":"1998","unstructured":"Avery AJ, Heron T, Lloyd D, Harris CM, Roberts D (1998) Investigating relationships between a range of potential indicators of general practice prescribing: an observational study. J Clin Pharm Ther 23:441","journal-title":"J Clin Pharm Ther"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/bmj.297.6663.1596","volume":"297","author":"J Collier","year":"1988","unstructured":"Collier J (1988) The cases for and against prescribing generic drugs: generic prescribing benefits patients. BMJ 297:1596","journal-title":"BMJ"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.320.7228.131","volume":"320","author":"T Walley","year":"2000","unstructured":"Walley T, Burrill P (2000) Generic prescribing: time to regulate the market? BMJ 320:131","journal-title":"BMJ"},{"key":"CR19","first-page":"146","volume":"90","author":"P McGettigan","year":"1997","unstructured":"McGettigan P, McManus J, O\u2019Shea B, Chan R, Feely J (1997) Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers\u2019 concerns. Ir Med J 90:146","journal-title":"Ir Med J"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/bmj.316.7128.333","volume":"316","author":"R Moore","year":"1998","unstructured":"Moore R, Tramer M, Carroll D, Wiffen P, McQuay H (1998) Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316:333","journal-title":"BMJ"},{"key":"CR21","volume-title":"Guide to good prescribing. A practical manual. World Health Organisation Action Programme on essential drugs","author":"Tde Vries","year":"1994","unstructured":"Vries Tde, Henning R, Hogerzeil H, Fresle D (1994) Guide to good prescribing. A practical manual. World Health Organisation Action Programme on essential drugs. World Health Organisation, Geneva"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bmj.312.7046.1563","volume":"312","author":"D Henry","year":"1996","unstructured":"Henry D, Lim L, Garcia Rodriguez L, Perez Gutthann S, Carson J, Griffin M et al (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative metanalysis. BMJ 312:1563","journal-title":"BMJ"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","volume":"160","author":"S Hernandez-Diaz","year":"2000","unstructured":"Hernandez-Diaz S, Garcia Rodriguez L (2000) Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation. An overview of epidemiologic studies published in the 1990s. Arch Intern Med 160:2093","journal-title":"Arch Intern Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s002280100310","volume":"57","author":"J Robertson","year":"2001","unstructured":"Robertson J, Fryer J, O\u2019Connell D, Smith A, Henry D (2001) Personal formularies: an index of prescribing quality? Eur J Clin Pharmacol 57:333","journal-title":"Eur J Clin Pharmacol"},{"key":"CR25","first-page":"284","volume":"35","author":"C Harris","year":"1985","unstructured":"Harris C, Fry J, Jarman B, Woodman E (1985) Prescribing\u2014a case for prolonged treatment. J R Coll Gen Pract 35:284","journal-title":"J R Coll Gen Pract"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/bmj.318.7182.507","volume":"318","author":"D O\u2019Connell","year":"1999","unstructured":"O\u2019Connell D, Henry D, Tomlins R (1999) Randomised controlled trial of effect of feedback on general practitioners\u2019 prescribing in Australia. BMJ 318:507","journal-title":"BMJ"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/qhc.9.3.159","volume":"9","author":"P Lagerlov","year":"2000","unstructured":"Lagerlov P, Loeb M, Andrew M, Hjortdahl P (2000) Improving doctors\u2019 prescribing behaviour through reflection on guidelines and prescription feedback: a randomised controlled study. Qual Health Care 9:159","journal-title":"Qual Health Care"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00005650-198403000-00002","volume":"22","author":"S Gehlbach","year":"1984","unstructured":"Gehlbach S, Wilkinson W, Hammond W (1984) Improving drug prescribing in a primary care practice. Med Care 22:193","journal-title":"Med Care"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00005650-198606000-00002","volume":"24","author":"C Hershey","year":"1986","unstructured":"Hershey C, Porter D, Breslau D, Cohen D (1986) Influence of simple computerised feedback on prescription charges in an ambulatory clinic. Med Care 24:472","journal-title":"Med Care"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bmj.311.6999.209","volume":"311","author":"FA Majeed","year":"1995","unstructured":"Majeed FA, Voss S (1995) Performance indicators for general practice. BMJ 311:209","journal-title":"BMJ"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm.157.3.157315","volume":"157","author":"P Barnes","year":"1998","unstructured":"Barnes P, Pedersen S, Busse W (1998) Efficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med 157:S1","journal-title":"Am J Respir Crit Care Med"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM200007273430407","volume":"343","author":"PJ Barnes","year":"2000","unstructured":"Barnes PJ (2000) Chronic obstructive pulmonary disease. N Engl J Med 343:269","journal-title":"N Engl J Med"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/bmj.322.7299.1413","volume":"322","author":"A Halligan","year":"2001","unstructured":"Halligan A, Donaldson L (2001) Implementing clinical governance: turning vision into reality. BMJ 322:1413","journal-title":"BMJ"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0876-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-004-0876-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0876-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:41:35Z","timestamp":1558687295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-004-0876-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,12]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1007\/s00228-004-0876-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,12]]}}}